A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Jerby-Arnon, Livnat, Shah, Parin, Cuoco, Michael S., Rodman, Christopher, Su, Mei-Ju, Melms, Johannes C., Leeson, Rachel, Kanodia, Abhay +44 more·2018·Cell

DOI 10.1016/j.cell.2018.09.006

Cited by (999)

Items 601–700 of 999

Functional analysis of RPS27 mutations and expression in melanoma
Alfredo Floristán, Leah J. Morales, Douglas Hanniford, Carlos N. Martinez, Elena Castellano‐Sanz, Igor Dolgalev, Alejandro J. Ulloa-Morales, Eleazar Vega‐Saenz de Miera, Una Moran, Farbod Darvishian et al. · 2019 · Pigment Cell & Melanoma Research
Clinical Implications of Inter- and Intratumor Heterogeneity of Immune Cell Markers in Lung Cancer
Zhao Wei, Bin Zhu, Amy A Hutchinson, Angela Cecilia Pesatori, Dario Consonni, Neil E. Caporaso, Tongwu Zhang, Difei Wang, Jianxin Shi, Maria Teresa Landi · 2021 · JNCI Journal of the National Cancer Institute
Single-Cell Epigenomics Reveals Mechanisms of Cancer Progression
Lindsay M. LaFave, Rachel E. Savage, Jason D. Buenrostro · 2022 · Annual Review of Cancer Biology
Inactivation of Hippo pathway characterizes a poor-prognosis subtype of esophageal cancer
Zihang Mai, Jianye Yuan, Hong Yang, Shuogui Fang, Xiuying Xie, Xinye Wang, Jiaxin Xie, Jing Wen, Jianhua Fu · 2022 · JCI Insight
Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response Rates
Attila A. Seyhan, Claudio Carini · 2022 · International Journal of Molecular Sciences
Use of 3D Spheroid Models for the Assessment of RT Response in Head and Neck Cancer
Marilyn Wegge, Rüveyda Dok, Ludwig Jerome Dubois, Sandra Nuyts · 2023 · International Journal of Molecular Sciences
Identification and validation of Birc5 as a novel activated cell cycle program biomarker associated with infiltration of immunosuppressive myeloid‐derived suppressor cells in hepatocellular carcinoma
Yun Liu, Xi Chen, Wenwu Luo, Yufei Zhao, Björn Nashan, Lei Huang, Xiaodong Yuan · 2023 · Cancer Medicine
A Population of Tumor-Infiltrating CD4+ T Cells Co-Expressing CD38 and CD39 Is Associated with Checkpoint Inhibitor Resistance
Ankita Mitra, Brian Thompson, Ann Strange, Carol M. Amato, Melinda Vassallo, Igor Dolgalev, Jonathan Hester-McCullough, Tomoaki Muramatsu, Diana A. Kimono, Amrutesh S. Puranik et al. · 2023 · Clinical Cancer Research
FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer models
Kristianne J. C. Galpin, Galaxia M. Rodriguez, Vincent Maranda, David P. Cook, Elizabeth A Macdonald, Humaira Murshed, Shan Zhao, Curtis W. McCloskey, A. Chruscinski, Gary A Levy et al. · 2024 · Scientific Reports
Single-cell transcriptome sequencing reveals aberrantly activated inter-tumor cell signaling pathways in the development of clear cell renal cell carcinoma
Junfeng Zhang, Fuzhong Liu, Wenjia Guo, Xing Bi, Shuai Yuan, Fuerhaiti Shayiti, Ting Shuang Pan, Kailing Li, Peng Chen · 2024 · Journal of Translational Medicine
Modulator of TMB-associated immune infiltration (MOTIF) predicts immunotherapy response and guides combination therapy
Zheng-Yu Qian, Yi‐Qian Pan, Xuexin Li, Yan‐Xing Chen, Hao‐Xiang Wu, Zexian Liu, Martin Košař, Jiří Bártek, Zixian Wang, Rui‐Hua Xu · 2024 · 中国科学通报：英文版
Targeting high circDNA2v levels in colorectal cancer induces cellular senescence and elicits an anti-tumor secretome
Shuang Wu, Xiangyu Dai, Yang Xia, Qingsong Zhao, Zhao Heng, Zhimin Shi, Xin Yin, Xue Liu, Aijie Zhang, Zhihui Yao et al. · 2024 · Cell Reports
Selenoprotein O Promotes Melanoma Metastasis and Regulates Mitochondrial Complex II Activity
Luiza Martins Nascentes Melo, Marie Sabatier, Vijayashree Ramesh, Krystina J. Szylo, Cameron S. Fraser, Alex Pon, Evann C. Mitchell, Kelly A. Servage, Gabriele Allies, Isa V. Westedt et al. · 2024 · Cancer Research
TBK1 Targeting Is Identified as a Therapeutic Strategy to Enhance CAR T-Cell Efficacy Using Patient-Derived Organotypic Tumor Spheroids
Yi Sun, Luke Maggs, Apekshya Panda, Samuel J. Wright, Angelina M. Cicerchia, Anne Jenney, Matthew D. Perricone, Caitlin E. Mills, Giulia Cattaneo, Marco Ventin et al. · 2025 · Cancer Immunology Research
DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor
Chuan Wang, Nur Syafinaz Zainal, San Jiun Chai, James Dickie, Chai Phei Gan, Natasha Zulaziz, Bryan Kit Weng Lye, Ruhcha V. Sutavani, Christian H. H. Ottensmeier, Emma Victoria King et al. · 2021 · Frontiers in Immunology
A TCF4/BRD4-dependent regulatory network confers cross-resistance to targeted and immune checkpoint therapy in melanoma
Joanna Poźniak, Dennis Pedri, Ewout Landeloos, Yannick Van Herck, Asier Antoranz, Panagiotis Karras, Ada Nowosad, Samira Makhzami, Greet Bervoets, Michael Dewaele et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
MCSP+ metastasis founder cells activate immunosuppression early in human melanoma metastatic colonization
Severin Guetter, Courtney König, Huiqin Koerkel-Qu, Aleksandra Markiewicz, Sebastian Scheitler, Marie Katzer, Mark Berneburg, Philipp Renner, Beatrix Cucuruz, Leonhard Guttenberger et al. · 2025 · Nature Cancer
Lessons from neoadjuvant immunotherapy in melanoma: understanding antitumour immunity and tumour escape
Francesca Fallarino, Christian U. Blank · 2025 · Nature reviews. Immunology
Single-Cell Sequencing in Cancer: Recent Applications to Immunogenomics and Multi-omics Tools
Michael C. Sierant, Jungmin Choi · 2018 · Genomics & Informatics
Cell Communication Network factor 4 promotes tumor‐induced immunosuppression in melanoma
Audry Fernández, Wentao Deng, Sarah L. McLaughlin, Anika Pirkey, Stephanie L. Rellick, Atefeh P. Razazan, David J. Klinke · 2022 · EMBO Reports
Integrating pathway knowledge with deep neural networks to reduce the dimensionality in single-cell RNA-seq data
Pelin Gundogdu, Carlos Loucera, Inmaculada Álamo-Álvarez, Joaquı́n Dopazo, Isabel Nepomuceno · 2022 · BioData Mining
Tackling tumor complexity with single-cell proteomics
Tamar Geiger · 2023 · Nature Methods
Tackling of Immunorefractory Tumors by Targeting Alternative Immune Checkpoints
Dharmindra Dulal, Andrew R. Boring, David Terrero, Tiffany L. Johnson, Amit Kumar Tiwari, Dayanidhi Raman · 2023 · Cancers
Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma: Current Evidence and Future Directions
Enrico Sammarco, Fiorella Manfredi, Amedeo Nuzzo, Marco Ferrari, Adele Bonato, Alessia Salfi, Debora Serafin, Luca Zatteri, Andrea Antonuzzo, Luca Galli · 2023 · Cancers
Stromal score is a promising index in tumor patients’ outcome determination
Xiaoxian Xu, Yu Xu, Wangxiong Hu, Wenjie Hong, Yichen Wang, Xiaojing Zhang, Xiaoji Fan, Tingzhang Wang, Hanmei Lou, Yanmei Yang et al. · 2023 · Heliyon
A Large-Scale Meta-Analysis Reveals Positive Feedback between Macrophages and T Cells That Sensitizes Tumors to Immunotherapy
Jing Yang, Qi Liu, Yu Shyr · 2023 · Cancer Research
ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC
Kathrin Böpple, Yaara Oren, Whitney S. Henry, Meng Dong, Sandra Weller, Julia Thiel, Markus Kleih, Andrea Gaißler, Damaris Zipperer, Hans‐Georg Kopp et al. · 2024 · Cell Death and Disease
Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma
Jordan Phillipps, George Nassief, Renée Morecroft, Tolulope Tosin Adeyelu, Andrew Elliott, Farah Rukhsana Abdulla, Ari M. Vanderwalde, Soohyung Park, Omar Hameed Butt, Alice Yao Zhou et al. · 2024 · npj Precision Oncology
Targeted transcriptional profiling of the tumor microenvironment reveals lymphocyte exclusion and vascular dysfunction in metastatic osteosarcoma
Laurie Sorenson, Yanfen Fu, Tressa Hood, Sarah E. Warren, Troy A. McEachron · 2019 · OncoImmunology
Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling
Joseph D. Butner, Geoffrey V. Martin, Zhihui Wang, Bruna Corradetti, Mauro Ferrari B, Nestor Esnaola, Caroline Chung, David S. Hong, James Welsh, Naomi Hasegawa et al. · 2021 · eLife
Targeting cellular senescence to combat cancer and ageing
Chen Wang, Xue Hao, Rugang Zhang · 2022 · Molecular Oncology
Adoptive Cell Therapy in Pediatric and Young Adult Solid Tumors: Current Status and Future Directions
John A. Ligon, Kristin M. Wessel, Nirali N. Shah, John W. Glod · 2022 · Frontiers in Immunology
EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling
Yubo Wang, Pu Chen, Man Zhao, Hongxin Cao, Yuelei Zhao, Meiju Ji, Peng Hou, Mingwei Chen · 2022 · Cell Death and Disease
ACAP1 Deficiency Predicts Inferior Immunotherapy Response in Solid Tumors
Qiyi Yi, Youguang Pu, Fengmei Chao, Po Bian, Lei Lv · 2022 · Cancers
CHRNA1 and its correlated-myogenesis/cell cycle genes are prognosis-related markers of metastatic melanoma
Mohamed Nabil Bakr, Haruko Takahashi, Yutaka Kikuchi · 2023 · Biochemistry and Biophysics Reports
Combination of multiple omics techniques for a personalized therapy or treatment selection
Chiara Massa, Barbara Seliger · 2023 · Frontiers in Immunology
Cathepsin V is correlated with the prognosis and tumor microenvironment in liver cancer
Junyu Liu, Wen Zhang, Zhijie Wang, Yichuan Wang, Tianxing Li, Yaping Wang, Jin Ding, Beifang Ning · 2023 · Molecular Carcinogenesis
Persisting cancer cells are different from bacterial persisters
Morgane Decollogny, Sven Rottenberg · 2024 · Trends in cancer
Myeloid-T cell interplay and cell state transitions associated with checkpoint inhibitor response in melanoma
Ramona Schlenker, Petra Catalina Schwalie, Steffen Dettling, Tamara Huesser, Anja Irmisch, Marisa Mariani, Julia M. Martínez Gómez, Alison Ribeiro, Florian Limani, Sylvia Herter et al. · 2024 · Med
Single-cell sequencing edges into clinical trials
Amanda B. Keener · 2019 · Nature Medicine
Co-regulation of the antagonistic RepoMan:Aurora-B pair in proliferating cells
Maria Giulia Manzione, Jan Rombouts, Mikhail Yu. Steklov, Lorenzo Pasquali, Anna A. Sablina, Lendert Gelens, Junbin Qian, Mathieu Bollen · 2020 · Molecular Biology of the Cell
2DImpute: imputation in single-cell RNA-seq data from correlations in two dimensions
Kaiyi Zhu, Dimitris Anastassiou · 2020 · Bioinformatics
https://cdrjournal.com/article/view/3531
Marco Moreira, Cédric Pobel, Nicolas Epaillard, Audrey Simonaggio, Stéphane Marie. Oudard, Yann Alexandre Vano · 2020 · Cancer Drug Resistance
Testing for Phylogenetic Signal in Single-Cell RNA-Seq Data
Jiří C. Moravec, Robert Lanfear, David L. Spector, Sarah D. Diermeier, Alex Gavryushkin · 2022 · Journal of Computational Biology
Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside
Amal Kamal Abdel‐Aziz, Mona Kamal Saadeldin, Paolo D’Amico, Stefania Orecchioni, Francesco Bertolini, Giuseppe Curigliano, Saverio Minucci · 2019 · European Journal of Cancer
Prediction of immunotherapy responsiveness in melanoma through single-cell sequencing-based characterization of the tumor immune microenvironment
Yucheng Dong, Zhizhuo Chen, Fan Yang, Jiaxin Wei, Jiuzuo Huang, Xiao Long · 2024 · Translational Oncology
inDrops-2: a flexible, versatile and cost-efficient droplet microfluidic approach for high-throughput scRNA-seq of fresh and preserved clinical samples
Simonas Juzėnas, Karolis Goda, Vaidotas Kiseliovas, Justina Žvirblytė, Àlvaro Quintanal-Villalonga, Juozas Siurkus, Juozas Nainys, Linas Mažutis · 2024 · Nucleic Acids Research
Decoding melanoma’s cellular mosaic to unlock immunotherapy potential
Joanna Poźniak, Jean‐Christophe Marine · 2025 · Trends in Cell Biology
The regulatory role of CDK4/6 inhibitors in tumor immunity and the potential value of tumor immunotherapy (Review)
Feifan He, Qiuchen Zhang, Yunjie Chen, Suli Ge, Yu Xie, Ruihong Sun, Yuqing Wu, Jian Xu · 2025 · International Journal of Molecular Medicine
Redirecting the Neo-Substrate Specificity of Cereblon-Targeting PROTACs to Helios
Alyssa L. Verano, Inchul You, Katherine A. Donovan, Nada Mageed, Hong Yue, Radosław P. Nowak, Eric S. Fischer, Eric S. Wang, Nathanael S. Gray · 2022 · ACS Chemical Biology
Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel
N. Eric Olson, Seamus P. Ragan, David J. Reiss, Jerill Thorpe, Yeonhee Kim, Jeremy S. Abramson, Candice McCoy, Kathryn J. Newhall, Brian A. Fox · 2023 · Molecular Cancer Therapeutics
Melanoma-intrinsic NR2F6 activity regulates antitumor immunity
Hyungsoo Kim, Yong-Mei Feng, Rabi Murad, J. Pozniak, C. Pelz, Yeqing Chen, B. Dalal, R. Sears, E. Sergienko, Michael Jackson et al. · 2022 · bioRxiv
Exploring the Complex and Multifaceted Interplay between Melanoma Cells and the Tumor Microenvironment
Magdalena Kuras · 2023 · International Journal of Molecular Sciences
Multimodal analysis unveils tumor microenvironment heterogeneity linked to immune activity and evasion
Óscar Lapuente-Santana, Gregor Sturm, J A Kant, Markus Außerhofer, Constantin Zackl, Maria Zopoglou, Nicholas McGranahan, Dietmar Rieder, Zlatko Trajanoski, Noel F.C.C. de Miranda et al. · 2024 · iScience
An In Vitro Model of Mast Cell Recruitment and Activation by Breast Cancer Cells Supports Anti-Tumoral Responses
Angélica Aponte-López, Jennifer Enciso, Samira Muñoz-Cruz, Ezequiel M. Fuentes‐Pananá · 2020 · International Journal of Molecular Sciences
UniPath: a uniform approach for pathway and gene-set based analysis of heterogeneity in single-cell epigenome and transcriptome profiles
Smriti Chawla, Sudhagar Samydurai, Say Li Kong, Zhengwei Wu, Zhenxun Wang, Wai Leong Tam, Debarka Sengupta, Vibhor Kumar · 2020 · Nucleic Acids Research
Nano-STING agonist-decorated microrobots boost innate and adaptive anti-tumor immunity
Yixin Wang, Zhaoting Li, Yu Chen, Allie Barrett, Fanyi Mo, Quanyin Hu · 2023 · Nano Research
Cellular Senescence and Immunosenescence in Melanoma: Insights From the Tumor Microenvironment
Lihua Xiong, Jian Cheng · 2025 · Cancer Medicine
In vivo generation of CAR myeloid cells through erythrocyte-mediated mRNA delivery for cancer immunotherapy
Xiaoqian Nie, Yuehua Liu, Yuting Song, Xingyun Yao, Yulin Chen, Hsiang‐Ying Lee, Xiaofei Gao · 2026 · Science Translational Medicine
Refining the Molecular Framework for Pancreatic Cancer with Single-cell and Spatial Technologies
Jimmy A. Guo, Hannah I. Hoffman, Colin D. Weekes, Lei Zheng, David Tsai Ting, William L. Hwang · 2021 · Clinical Cancer Research
IRF8 Regulates Intrinsic Ferroptosis through Repressing p53 Expression to Maintain Tumor Cell Sensitivity to Cytotoxic T Lymphocytes
Dakota B. Poschel, Mercy Kehinde‐Ige, John David Klement, Dafeng Yang, Alyssa D. Merting, Natasha M. Savage, Huidong Shi, Kebin Liu · 2023 · Cells
Proteomic and single-cell landscape reveals novel pathogenic mechanisms of HBV-infected intrahepatic cholangiocarcinoma
Yifei Shen, Shuaishuai Xu, Chanqi Ye, Qiong Li, Ruyin Chen, Wei Wu, Qi Jiang, Yunlu Jia, Xiaochen Zhang, Longjiang Fan et al. · 2023 · iScience
Targeting Upregulated cIAP2 in SOX10-Deficient Drug Tolerant Melanoma
McKenna Q. Glasheen, Signe Caksa, Amelia G. Young, Nicole A. Wilski, Connor A. Ott, Inna Chervoneva, Keith T. Flaherty, Meenhard Herlyn, Xiaowei Xu, Andrew E. Aplin et al. · 2023 · Molecular Cancer Therapeutics
Skin in the game: a review of single-cell and spatial transcriptomics in dermatological research
Samuel Schepps, Jonathan Xu, Henry Y. Yang, Jenna L. Mandel, Jaanvi Mehta, Julianna Tolotta, Nicole Baker, Volkan Tekmen, Neda Nikbakht, Paolo M. Fortina et al. · 2024 · Clinical Chemistry and Laboratory Medicine (CCLM)
Unveiling major histocompatibility complex-mediated pan-cancer immune features by integrated single-cell and bulk RNA sequencing
Hao-Ran Feng, Xiaonan Shen, Xiaoming Zhu, Wen-Tao Zhong, De-Xiang Zhu, Ji Zhao, Yan-Jie Chen, Feng Shen, Kun Liu, Li Liang · 2024 · Cancer Letters
Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th–1 December 1st, 2018, Naples, Italy)
Paolo A. Ascierto, Sanjiv S. Agarwala, Gerardo Botti, Alfredo Budillon, Michael A. Davies, Reinhard Dummer, Marc S. Ernstoff, Soldano Ferrone, Silvia Chiara Formenti, Thomas Frank Gajewski et al. · 2019 · Journal of Translational Medicine
Single-Cell Epigenomics in Cancer: Charting a Course to Clinical Impact
Danielle R. Bond, Kumar Uddipto, Anoop Kumar Enjeti, Heather J Lee · 2020 · Epigenomics
Single-cell technologies and analyses in hematopoiesis and hematological malignancies
Ignacio Campillo‐Marcos, Damiana Álvarez‐Errico, Regina Antoni Alandes, Elisabetta Mereu, Manel Esteller · 2021 · Experimental Hematology
High-Dimensional Single-Cell Transcriptomics in Melanoma and Cancer Immunotherapy
Camelia Y. J. Quek, Xinyu Bai, Georgina Venetia Long, Richard A. Scolyer, James S. Wilmott · 2021 · Genes
PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer
Adam Kraya, Kara N. Maxwell, Monika A. Eiva, Bradley Stephen Wubbenhorst, John B. Pluta, Michael D. Feldman, Anupma Nayak, Daniel J. Powell, Susan M. Domchek, Robert H. Vonderheide et al. · 2022 · JCO Precision Oncology
The SRPK inhibitor N-(2-(piperidin-1-yl)-5-(trifluoromethyl)phenyl) isonicotinamide (SRPIN340) increases the immune response against metastatic melanoma in mice
Gabriela Alves Moreira, Mônica Maria Magalhães Caetano, Juliana Alves do Vale, Janine Cerqueira de Paiva, Victor Hugo Sousa Gonçalves, Alisson Andrade Almeida, Lucas Viana Gomes Silva, Fernanda Rebellato Giordano Martim, Marcus Vinícius de Andrade Barros, Gabriela Rapozo Guimarães et al. · 2022 · Biochemical Pharmacology
Identification of fatty acid metabolism–related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma
Yujian Xu, Youbai Chen, Weiqian Jiang, Xiangye Yin, Dongsheng Chen, Yuan Chi, Yuting Wang, Julei Zhang, Qixu Zhang, Yan Han · 2022 · Frontiers in Immunology
Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma
Akira Kazama, Vladimir N. Bilim, Masayuki Tasaki, Tsutomu Anraku, Hiroo Kuroki, Yuko Shirono, Masaki Murata, Kaede Hiruma, Yoshihiko Tomita · 2022 · Scientific Reports
Evaluation of single-cell RNAseq labelling algorithms using cancer datasets
Erik Christensen, Ping Luo, Andrei L. Turinsky, Mia Husić, Alaina Mahalanabis, Alaine Naidas, J. Javier Díaz-Mejía, Michael Brudno, Trevor J. Pugh, Arun K Ramani et al. · 2022 · Briefings in Bioinformatics
Characterization and Optimization of Multiomic Single-Cell Epigenomic Profiling
Letícia Sandoval, Wazim Mohammed Ismail, Amelia Mazzone, Mihai Gabriel Dumbrava, Jenna A. Fernandez, Amik Munankarmy, Terra L. Lasho, Moritz Binder, Vernadette A. Simon, Kwan‐Hyun Kim et al. · 2023 · Genes
The Ins and Outs of Chemokine-Mediated Immune Cell Trafficking in Skin Cancer
Andrew On Wah Yam, Tatyana Chtanova · 2019 · Frontiers in Immunology
Breaking barriers for T cells by targeting the EPHA2/TGF-β/COX-2 axis in pancreatic cancer
Jose Ramon Conejo-Garcia · 2019 · Journal of Clinical Investigation
Understanding genetic determinants of resistance to immune checkpoint blockers
Sandrine Aspeslagh, Roman M. Chabanon, Stéphane Champiat, Sophie C. Postel-Vinay · 2019 · Seminars in Cancer Biology
Lymphoma Heterogeneity Unraveled by Single-Cell Transcriptomics
Loïc Ysebaert, Anne Quillet‐Mary, Marie Tosolini, Frédéric Pont, Camille Laurent, Jean‐Jacques Fournié · 2021 · Frontiers in Immunology
Cholinergic T cells revitalize the tumor immune microenvironment: TIME to ChAT
Chunxing Zheng, Shaofeng Liu, Nastaran Fazel Modares, Michael St. Paul, Tak W. Mak · 2025 · Nature Immunology
Metabolic networks in the tumor microenvironment: roles of amino acid and lipid metabolism pathways in cancer progression and therapy
Yulseung Sung, Dae Kyoung Kim, Jun Se Kim, Seong-Jang Kim, Jae Ho Kim, Jung Min Han · 2026 · Experimental & Molecular Medicine
CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer Analysis
Wenrui Ye, Cong Luo, Chenglong Li, Zhixiong Liu, Fangkun Liu · 2021 · Journal of Cancer
Upregulation of MTA1 in Colon Cancer Drives A CD8+ T Cell-Rich But Classical Macrophage-Lacking Immunosuppressive Tumor Microenvironment
Yantong Zhou, Peng Nan, Chunxiao Li, Hongnan Mo, Ying Zhang, Haijuan Wang, Dongkui Xu, Fei Ma, Haili Qian · 2022 · Frontiers in Oncology
STUB1 is an intracellular checkpoint for interferon gamma sensing
Simon Ng, Shuhui Lim, Adrian Chong Nyi Sim, Ruban Mangadu, Ally Lau, Chunsheng Zhang, Sarah Bollinger Martinez, Arun Chandramohan, U-Ming Lim, Samantha Shu Wen Ho et al. · 2022 · Scientific Reports
The Potent and Paradoxical Biology of Cellular Senescence in Cancer
Paul Bernard Romesser, Scott W. Lowe · 2023 · Annual Review of Cancer Biology
CD83 expression characterizes precursor exhausted T cell population
Zhiwen Wu, Toshiaki Yoshikawa, Satoshi Inoue, Yusuke Ito, Hitomi Kasuya, Takahiro Nakashima, Haosong Zhang, Saki Kotaka, Waki Hosoda, Shiro Suzuki et al. · 2023 · Communications Biology
Enhanced systemic tumor suppression by in situ vaccine combining radiation and OX40 agonist with CpG therapy
Zhichen Sun, Yanhong Chu, Jie Xiao, Yueling Yang, Fanyan Meng, Xinyue Wang, Yanbing Dong, Junmeng Zhu, Yirong Wu, Lanqun Qin et al. · 2023 · Journal of Translational Medicine
Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpoints
Alexa Christine Cannon, Konstantin Budagyan, Cristina Uribe‐Alvarez, Alison Kurimchak, Daniela Araiza‐Olivera, Kathy Qi Cai, Suraj Peri, Yan Zhou, James S. Duncan, Jonathan Chernoff · 2024 · Oncogene
B7-H3 is associated with the armored-cold phenotype and predicts poor immune checkpoint blockade response in melanoma
Bozhi Shen, Jie Mei, Rui Xu, Yun Cai, Mengyun Wan, Ji Zhou, Junli Ding, Yichao Zhu · 2024 · Pathology - Research and Practice
IFN-α/β/IFN-γ/IL-15 pathways identify GBP1-expressing tumors with an immune-responsive phenotype
Lei Wang, Yuxuan Wei, Zheng Jin, Fangfang Liu, Xuchang Li, Xiao Zhang, Xiumei Bai, Qingzhu Jia, Bo Zhu, Qian Chu · 2024 · Clinical and Experimental Medicine
Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy
Avishai Maliah, Nadine Santana-Magal, Shivang Parikh, Sagi Gordon, Keren Reshef, Yuval Sade, Aseel Khateeb, Alon Richter, Amit Gutwillig, Roma Parikh et al. · 2024 · Nature Communications
Arsenic trioxide (ATO) induced degradation of Cyclin D1 sensitized PD-1/PD-L1 checkpoint inhibitor in oral and esophageal squamous cell carcinoma
Guanxia Zhu, Xia Li, Jiong Li, Wei Zhou, Zhongjian Chen, Yun Fan, Youhua Jiang, Yue Zhao, Guogui Sun, Weimin Mao · 2020 · Journal of Cancer
Anti-cancer therapy with cyclin-dependent kinase inhibitors: impact and challenges
Marika Reinius, Elizabeth Catherine Smyth · 2021 · Expert Reviews in Molecular Medicine
Modulation of Type I Interferon Responses to Influence Tumor-Immune Cross Talk in PDAC
Carlotta Cattolico, Peter Bailey, Simon T. Barry · 2022 · Frontiers in Cell and Developmental Biology
Pharmacological intervention of cholesterol sulfate-mediated T cell exclusion promotes antitumor immunity
Takaaki Tatsuguchi, Takehito Uruno, Yuki Sugiura, Kounosuke Oisaki, Daisuke Takaya, Daiji Sakata, Yoshihiro Izumi, Takaya Togo, Yuko Hattori, Kazufumi Kunimura et al. · 2022 · Biochemical and Biophysical Research Communications
Solving the puzzle of what makes immunotherapies work
Xiaoxiao Ma, Timothy An-thy Chan · 2022 · Trends in cancer
JAML immunotherapy targets recently activated tumor-infiltrating CD8+ T cells
S. Eschweiler, A. Wang, C. Ramírez-Suástegui, A. von Witzleben, Yingcong Li, Serena J. Chee, Hayley Simon, M. Mondal, M. Ellis, G. Thomas et al. · 2023 · Cell Reports
spongEffects: ceRNA modules offer patient-specific insights into the miRNA regulatory landscape
Fabio Boniolo, Markus Hoffmann, Norman Roggendorf, Bahar Tercan, Jan Baumbach, Mauro A. A. Castro, A Gordon Robertson, Dieter Saur, Markus List · 2023 · Bioinformatics
HLA Class II Loss and JAK1/2 Deficiency Coevolve in Melanoma Leading to CD4 T-cell and IFNγ Cross-Resistance
Simone Stupia, Christina Heeke, Alicia Brüggemann, Anne Zaremba, Beatrice Thier, Julia Kretz, Antje Sucker, Manuel Philip, Gennadiy Zelinskyy, Soldano Ferrone et al. · 2023 · Clinical Cancer Research
The Sophisticated Transcriptional Response Governed by Transposable Elements in Human Health and Disease
Federica Marasca, Erica Gasparotto, Benedetto Polimeni, Rebecca Vadalà, Valeria Ranzani, Beatrice Bodega · 2020 · International Journal of Molecular Sciences